Get 40% Off
💰 Buffett reveals a $6.7B stake in Chubb. Copy the full portfolio for FREE with InvestingPro’s Stock Ideas toolCopy Portfolio

HCA Healthcare's (HCA) Q2 Earnings Miss Estimates, Down Y/Y

Published 07/29/2019, 09:53 PM
Updated 07/09/2023, 06:31 AM
US500
-
HCA
-

Have you been eager to see how HCA Healthcare, Inc. (NYSE:HCA) performed in Q2 in comparison with the market expectations?

Let’s quickly scan through the key facts from this leading hospital company’s earnings release this morning.

Earnings Miss Estimates

HCA Healthcare reported second quarter 2019 adjusted earnings of $2.21 per share, missing the Zacks Consensus Estimate by 11.2%. Moreover, the bottom line declined 3.5% year over year.

HCA Healthcare, Inc. Price, Consensus and EPS Surprise

HCA Healthcare, Inc. price-consensus-eps-surprise-chart | HCA Healthcare, Inc. Quote

How Was the Estimate Revision Trend?

You should note that the earnings estimate for HCA Healthcare depicted neutral stance prior to the earnings release. The Zacks Consensus Estimate remained unchanged at $10.40 per share over the last seven days.

Revenue Miss Estimates

HCA Healthcare generated revenues of $12.6 billion, missing the Zacks Consensus Estimate by 0.2%. However, the same was up 9.3% year over year.

Key Stats to Note

Same facility admissions and equivalent admissions was up, by 2.1% and 2.6%, respectively in the quarter under review. Same facility revenue per equivalent admission grew 1.7% year over year.

Expenses increased nearly 10.6% year over year to $10.3 billion.

Adjusted EBITDA totaled $2.2 billion, up 3% year over year.

As of Jun 30, 2019, HCA operated 184 hospitals and around 2000 sites of care including surgery centers, freestanding emergency rooms, urgent care centers and physician clinics.

Guidance Revised

The company expects revenues for 2019 to be in the band of $50.5 to $51.5 billion. Adjusted EBITDA is projected in between $9.60 and $9.85 billion, up from the prior projection of 9.45 and $9.85 billion. EPS of the company is expected to be in between $10.25 to $10.65, up from the prior projection of $9.80-$10.40 per share.

What Zacks Rank Says

HCA Healthcare carries a Zacks Rank #1 (Strong Buy). However, since the latest earnings performance is yet to be reflected in the estimate revisions, the rank is subject to change.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

You can see the complete list of today’s Zacks #1 Rank stocks here.

Check back later for our full write up on this HCA Healthcare earnings report!

Today's Best Stocks from Zacks

Would you like to see the updated picks from our best market-beating strategies? From 2017 through 2018, while the S&P 500 gained +15.8%, five of our screens returned +38.0%, +61.3%, +61.6%, +68.1%, and +98.3%.

This outperformance has not just been a recent phenomenon. From 2000 – 2018, while the S&P averaged +4.8% per year, our top strategies averaged up to +56.2% per year.

See their latest picks free >>



HCA Healthcare, Inc. (HCA): Free Stock Analysis Report

Original post

Zacks Investment Research

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.